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Conclusion: Combined approach of surgica[ re- 
section and the use of the investigationa[ drug 
posaconazote was key to successfutty treat the 
highty [etha[ invasive putmonary mucormycosis n
a heart transptant patient requiring continuous im- 
munosuppression. 
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Introduction E Background: Infections represent 
a significant hreat in sotid-organ recipients. How- 
ever, a certain number of infections can be pre- 
vented by immunizing patients before their trans- 
ptantation. The aim of this study is to determine 
the immunization revers of chitdren undergoing 
transptantation and to assess their capacity to 
maintain protective revers after surgery. 
Methods: Charts of 44 chitdren transptanted with 
cadaveric rivers between 1990 and 2002 at the 
Chitdren's Hospita[ of Geneva were reviewed. Vac- 
cination types and schedutes were compared to 
current recommendations and antibody responses 
to certain antigens were estabtished pre- and post- 
transptantation. 
Results: Onty 43% of patients were up to date for 
diphtheria, tetanus, acettutar pertussis, and potio 
vaccines at the pre-transptant visit, white 44% of 
chitdren order than 12 months had received their 
required meastes-mumps-rubetta shots. Six out of 
44 chitdren had received at [east one dose of hep- 
atitis B vaccine, white onty 2 patients had received 
at [east one dose of hepatitis A vaccine. After 
immunization, and one year after transptantation, 
onty 14/44 patients had detectabte anti-HBs anti- 
bodies and 7/18 had anti-HAV antibodies. Varicetta 
antibodies were undetectabte in 15/19 patients 
immunized prior to transptantation. 
Conclusions: This study hightights the need to en- 
force vaccination before transptantation, fottow- 
up on vaccine-induced immunity, and adapt vac- 
cination schedutes after river transptantation i
chitdren, especiatty for non-tire vaccines which are 
universatty recommended in this poputation. 
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Background E Methods: Respiratory syncytial 
virus (RSV) infections in tung transptant pa- 
tients (LTP) have been associated with mortat- 
ity rates between 10% and 70%. Immunogtobu- 
tines (IG), ribavirine and pavitizumab have been 
suggested for both therapeutic and pre-emptive 
therapeutic approaches, however they are [imited 
by toxicity concerns and high costs. In order to 
design a decisiona[ treatment ree we describe 
four cases of proven tower respiratory tract RSV 
infections in tung transptant patients ittustrating 
possibte different ctinica[ approaches. 
Results: Case 1: A 54-year-otd femate LTP was 
hospitatized with cough, bronchitis and rhinorrhea. 
The bronchoatveotar r vage (BAL) grew 105 CFU/m[ 
of S. aureus and S. marcescens suggesting a bacte- 
ria[ pneumonia responding wet[ to cefepime and a 
transient reduction in immunosuppression. Subse- 
quentty a positive PER resutt for RSV was obtained 
from the same BAL. She evotved favourabty with- 
out a therapy against RSV. Case 2: A 28-year-otd 
mate LTP was hospitatized for fever and "common 
cord'. Putmonary functions were ctearty worsened 
compared to two weeks before. The BAL resutts 
suggested a vira[ infection that was treated by a 
reduction in immunosuppression. After one week 
the putmonary functions and ctinica[ symptoms had 
improved. A positive PER for RSV was obtained 
from the origina[ BAL. A specific treatment against 
RSV was not necessary. Case 3: A 48-year-otd fe- 
mate LTP was hospitatized for rhinitis, cough and 
increased sputum production. A tung biopsy re- 
reared an acute A3 rejection. The BAL yietded a 
positive vira[ cutture and PER for RSV. IG associated 
with ribavirine and pavitizumab were administered 
before the treatment of the rejection by anti- 
thymogtobutines. He evotved favourabty without 
significant side effect of the anti-RSV treatment. 
Case 4: A 62-year-otd tung transptant patient was 
hospitatized for rhinorrhea, fever, myatgia, cough, 
severe wheezing and ground grass opacities in the 
middte robe. Withdrawa[ of mycophenotate was 
fottowed by a significant spirometric and ctinica[ 
improvement. Secondarity the BAL yietded a pos- 
itive PER resutt for RSV. He evotved favourabty 
without specific anti-RSV treatment. 
